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Abstract Adherents to the Jewish faith have resided in
numerous geographic locations over the course of three
millennia. Progressively more detailed population genetic
analysis carried out independently by multiple research
groups over the past two decades has revealed a pattern for
the population genetic architecture of contemporary Jews
descendant from globally dispersed Diaspora communities.
This pattern is consistent with a major, but variable com-
ponent of shared Near East ancestry, together with variable
degrees of admixture and introgression from the corre-
sponding host Diaspora populations. By combining analy-
sis of monoallelic markers with recent genome-wide
variation analysis of simple tandem repeats, copy number
variations, and single-nucleotide polymorphisms at high
density, it has been possible to determine the relative
contribution of sex-specific migration and introgression to
map founder events and to suggest demographic histories
corresponding to western and eastern Diaspora migrations,
as well as subsequent microevolutionary events. These
patterns have been congruous with the inferences of many,
but not of all historians using more traditional tools such as
archeology, archival records, linguistics, comparative
analysis of religious narrative, liturgy and practices.
Importantly, the population genetic architecture of Jews
helps to explain the observed patterns of health and dis-
ease-relevant mutations and phenotypes which continue to
be carefully studied and catalogued, and represent an
important resource for human medical genetics research.
The current review attempts to provide a succinct update of
the more recent developments in a historical and human
health context.
Introduction
Since their emergence as a national and religious group in
the Middle East over 2,000 years ago (Biran and Naveh
1993), Jews have maintained continuous cultural and reli-
gious traditions amid a series of Diasporas (Ben-Sasson
1976). Along the way, others were converted into the
Jewish fold. The origins and relatedness of the various
Jewish groups have been much speculated upon over the
past century. Jews have described themselves as a ‘‘peo-
ple’’, based on their shared religion, without a clear indi-
cation of the genetic lines of descent since their early
history. Albert Einstein captured this uncertainty when he
wrote to the Berlin rabbis in 1921 ‘‘I notice that the word
Jew is ambiguous in that it refers (1) to nationality and
origin, (2) to the faith’’ (Einstein et al. 1987).
With the advent of modern population genetics based on
analysis of genetic markers in the second half of the
twentieth century, investigators have attempted to catego-
rize the origins and relatedness of Jewish people. Because
relatively few polymorphic markers were available at first,
the early studies focused on genetic distances between
groups and established hierarchies based on these distances
(Bonne-Tamir et al. 1978a, b, 1977; Carmelli and Cavalli-
Sforza 1979; Karlin et al. 1979; Kobyliansky et al. 1982;
Electronic supplementary material The online version of this
article (doi:10.1007/s00439-012-1235-6) contains supplementary
material, which is available to authorized users.
H. Ostrer
Departments of Pathology and Genetics, Albert Einstein College
of Medicine, Bronx, NY 10461, USA
K. Skorecki (&)
Rappaport Faculty of Medicine and Research Institute,
Technion-Israel Institute of Technology, Rambam Health Care
Campus, 8 Ha’Aliyah Street, 31096 Haifa, Israel
e-mail: skorecki@tx.technion.ac.il
123
Hum Genet (2013) 132:119–127
DOI 10.1007/s00439-012-1235-6
Livshits et al. 1991). Population genetics has been
enhanced by the identification of millions of polymorphic
markers that reside in close proximity to one another along
the genome and that vary in their allele frequencies among
populations. These discoveries have led to greater precision
for estimates of genetic distances. These discoveries have
also led to new types of analyses that were not available in
the past. The analyses have included deconvolution of
ancestry for whole genomes or for segments of individual
genomes and analysis of segmental sharing among indi-
viduals that provide greater accuracy for estimating their
degree of relatedness (Atzmon et al. 2010; Bryc et al.
2010).
At the same time, genetic analyses of diseases have
continued in Jewish populations. These have included
diseases with a clear Mendelian basis, rare syndromes often
identified first in a single family, common conditions that
are more prevalent in Jewish populations, and common
conditions for which the complexity might be simplified by
studying Jewish populations. Interest in studying these
disorders has accelerated with the advent of genomic
sequence-based personalized medicine research (Ostrer
2011). Here, we provide a description of the population
genetics of the Jewish people based on these recent dis-
coveries and a progress report on the genetic basis of
diseases.
History as a guide to understanding Jewish population
genetics
The history of the Jewish people from Classical Antiquity
onward provides a guide to understanding their population
genetics and is most accurately recorded beginning at the
time of the Greek and Roman Empires. Up to 6 million
Jews are thought to have resided in the Roman Empire,
comprising 10 % of the total population (Fishberg 1911).
In the period immediately preceding the fall of the Second
Temple in 70 CE, adherents to Judaism were located
throughout the Roman Empire, to the west, and extended
into the Arsacid Empire in the east (Isaac 1998). These
Jews are likely to have been the ancestors of the subsequent
Jewish Diaspora populations that lived in the Middle East
(‘‘Mizrahi’’), Europe (‘‘Ashkenazi and Sephardic’’) and
North Africa (Baron 1952). The number of adherents to
Judaism residing outside of the Kingdom of Judea is
thought to have greatly exceeded those residing within
Judea with the largest communities in Alexandria in Egypt
and Antioch in contemporary Turkey. Evidence for these
communities remains in the archeological record, such as
the well-studied community in Dura-Europos then at the
boundary of the Roman Empire and now in present-day
Syria (Chi et al. 2011). Most introgression with non-Jews
occurred during times of relative liberalism and tolerance,
including the Hasmonean period in Classical Antiquity
(140–37 BCE) and modern times (Shanks 1988). Intro-
gression between Jewish groups also occurred following
the Spanish Inquisition when Sephardic Jews left the Ibe-
rian Peninsula (1492–96 CE) and migrated to Italy, the
Balkans, Syria, Morocco, and Algeria, often settling within
existing Jewish communities (Stillman 1991). Although
not sustaining communities that were recognizably Jewish,
Sephardic Jews also migrated to the New World and con-
tributed to the formation of contemporary Hispanic and
Latino non-Jewish populations (Hordes 2005). Since the
fall of the Second Temple and the end of the Judean
kingdom in 70 CE, religious law and anti-Semitism in the
emerging Christian and Islamic worlds favored marrying
within the Jewish fold (Cohen 1999; Goldstein and Evans
2012; Wistrich 2010).
Judaism was also brought outside the Roman Empire to
Yemen, Ethiopia, India, and China. Many of these com-
munities were long-standing and were observed by Ben-
jamin of Tudela during his travels of the twelfth century
(Benjamin 1983). The origins of these communities have
been the subject of considerable speculation. Some com-
munities have been thought to be the descendants of the
Lost Tribes that were forced into Assyrian exile following
the destruction of the Kingdom of Israel in 622 BCE,
although unsupported by historical evidence (Parfitt 2002;
Gonen 2002). Some commentators have suggested that
these communities may have been established by Jewish
traders (usually men) who brought their ideas and genes
and converted members of the local population (Goldstein
2008). Within these communities, the contemporary com-
position may have been influenced by the number and
origins of the founders as well as by the subsequent
admixture events. Forced and voluntary conversion out of
the Jewish faith has been well documented and has left
genetic imprint on some contemporary non-Jewish popu-
lations (Velez et al. 2011).
Population genetics as a guide to understanding Jewish
history
Early population genetic studies based on blood groups and
serum markers provided evidence that most Jewish Dias-
pora groups originated in the Middle East and that paired
Jewish populations were more similar genetically than
paired Jewish and non-Jewish populations (Bonne-Tamir
et al. 1978a, b, 1977; Carmelli and Cavalli-Sforza 1979;
Karlin et al. 1979; Kobyliansky et al. 1982; Livshits et al.
1991). These studies differed in their inferences regard-
ing the degree of admixture with local populations.
Subsequent studies of the monoallelic Y chromosomal and
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mitochondrial DNA haplotypes demonstrated founder
effects of both Middle Eastern and local origin, but did not
adequately resolve the degree of admixture. To resolve this
issue and to improve the understanding about the related-
ness of contemporary Jewish groups, our research teams
and others have independently performed genome-wide
analyses of Diaspora Jewish groups and comparison with
neighboring populations (Atzmon et al. 2010; Behar et al.
2010; Campbell et al. 2012; Kopelman et al. 2009; Bray
et al. 2010; Listman et al. 2010). These studies varied in the
specific populations analyzed and in the number of individuals
included from each population. Yet, they came to remarkably
similar conclusions, providing evidence for shared genetic
ancestries among major Jewish Diaspora groups together with
variation in admixture with local populations.
By principal component analysis, it was observed that
the Jewish populations of Europe, North Africa, and the
Middle East formed a tight cluster that distinguished them
from their non-Jewish neighbors (Fig. 1). Within this
central cluster, each of these Jewish populations formed its
own subcluster, in addition to the more remote localization
of members of some Diaspora communities. The observa-
tion of a major central tight cluster was supported by sta-
tistical metrics for genetic distances (Fst, allelic sharing
distances). Nearest neighbor-joining analysis robustly
supported shared origins of most Jewish populations with
clearly discernible European/Syrian/North African and
Middle Eastern branches (Fig. 2; Campbell et al. 2012).
Turkish, Greek, and Italian Jews shared a common branch,
with Ashkenazi and Syrian Jews forming connections to
this branch. The North African populations added a sub-
branch to the European/Syrian branch. In turn, this North
African sub-branch bifurcated into Moroccan, Algerian and
Tunisian, Djerban, Libyan sub-branches. More detailed
PCA analysis showed that the Tunisian Jewish group was
identifiable by two clusters, one with proximity to Libyan
Jews and the other with proximity to Moroccan Jews.
Moreover, by PCA analysis, the North African Jewish
populations were orthogonal to contemporary non-Jewish
North African populations from Western Sahara, North and
South Morocco, Algeria, Tunisia, Libya, and Egypt. The
Middle Eastern Jewish branch included the Iranian, Iraqi
and Georgian Jews as well as the non-Jewish Adygei.
Even groups that fell outside of the shared Jewish
population cluster identified by PCA such as Ethiopian
Beta Israel, Yemenite, Indian Bene Israel, and Indian
Cochin Jews, formed their own subclusters indicating that
they were distinct, homogeneous populations. On the
nearest-neighbor-joining tree, the Yemenite Jews were on a
branch between Palestinians and Bedouins, and the Ethi-
opian Beta Israel Jews were on a distinctive distal branch.
Uniparental genome region analysis provided additional
insights, for example, supporting male predominant Middle
East Jewish origins for the Bene Israel population (Behar
et al. 2010).
The genetic sharing within and among these populations
occurred not only at the single-nucleotide polymorphism
(SNP) level, but also at the levels of copy number variants
(CNVs) and, where studied, identical-by-descent (IBD)
segment sharing (Fig. 3; Atzmon et al. 2010; Campbell
et al. 2012). The IBD segment sharing was greater within
specific Jewish populations and as expected highest among
Jewish populations with greater degrees of inbreeding,
such as Libyan, Djerban, and Tunisian Jews. In fact, the
general degree of sharing within populations was similar to
what one might observe for fourth to fifth cousins. This
included the Yemenite as well as the Middle Eastern,
European and North African Jews. Detailed patterns of
segment sharing provided still further insights. Thus, for
example, a pattern of more numerous shorter segments
shared among Ashkenazi Jews is consistent with a popu-
lation bottleneck effect (see below). Notably, the degree of
sharing between Jewish populations was also greater than
the sharing between Jewish and non-Jewish populations.
These studies showed that Jews have a tapestry of shared
DNA threads with other Jews and that no one thread is
sufficient to define Jewish ancestry.
Fig. 1 Principal components 1 and 2 analysis of major central cluster
of Jewish populations combined with other Old World populations
(indicated by different colored balls). Figure based on data in Behar
et al. (2010), which also provides and illustrates the data for subjects
remote from the major central cluster. Blow-up of data for Jewish,
European, and Middle Eastern populations is also shown
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These studies also demonstrated that the history of the
Jewish Diasporas could be observed in the genomes of
Jewish people by patterns of admixture. A high degree of
European admixture (30–60 %) was observed among
Ashkenazi, Sephardic, Italian and Syrian Jews. The North
African Jewish groups demonstrated North African and
Middle Eastern admixture with varying European admix-
ture. The proportion of European admixture among North
African Jewish groups increased from east to west, with
Moroccan Jews demonstrating the highest proportion. In
contrast, the corresponding non-Jewish North African host
populations demonstrated substantially higher inferred
North African ancestry and less European ancestry.
The closest genetic neighbors to most Jewish groups
were the Palestinians, Israeli Bedouins, and Druze in
addition to the Southern Europeans, including Cypriots.
The genetic clusters formed by each of these non-Jewish
Middle Eastern groups reflect their own histories of
Fig. 2 Neighbor-joining tree
showing the relationship of
European, Jewish, Middle
Eastern, and North African
populations, using Fst as the
distance metric. The neighbor-
joining algorithm used Fst as the
distance metric input for
calculation of a matrix
specifying the distance between
each pair of groups and then
iterates until the tree is resolved
and branch lengths discerned.
The tree was rooted using the
reference mixed Central and
Southern African population as
an out-group. Major population
groups are labeled at the right
Fig. 3 Genome-wide identity-by-descent (IBD) sharing for the
average pair of individuals within (a left) and across populations
(a right, b). Genome-wide IBD analysis estimates kinship based on
sharing of DNA sequence segment similarities as determined by
variable sites across the genome. With the exception of non-Jewish
Tunisian samples, IBD sharing is higher within Jewish groups,
reflecting higher levels of endogamy. Jewish populations exhibit
higher sharing with other Jewish populations than with geographically
near groups. The average total sharing across Jewish populations is
generally higher than the sharing across other population pairs
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endogamy. Their proximity to one another and to European
and Syrian Jews suggested a shared genetic history of
related Semitic and non-Semitic Mediterranean ancestors
who followed different religious and tribal affiliations.
Earlier studies of Israeli Jewish, Palestinian and Druze
populations made a similar observation by demonstrating
the proximity of these two non-Jewish populations to
Ashkenazi and Iraqi Jews (Rosenberg et al. 2001; Kopel-
man et al. 2009).
Monoallelic markers provide insight into founder
effects
Monoallelic markers, Y chromosomal and mitochondrial
haplogroups, have proven to be very useful for under-
standing the patrilineal and matrilineal origins of Jewish
Diaspora groups. Y chromosomal analysis showed that
most Diaspora Jews whose ancestors lived in the Middle
East, Europe or North Africa, one to two generations ago,
were descended from a smaller group of Middle Eastern
men (Hammer et al. 2000). Similar Y chromosomal lin-
eages have been found among Christian and Muslim men
who live in the Middle East today. Seven Y chromosome
major branches (E3b, G, J1, J2, Q, R1a1, and R1b) that are
prevalent among Ashkenazi Jews account for 80 % or more
of the total (Behar et al. 2004). Four of these (E3b, G, J1,
J2, Q) were part of the ancestral gene pool transmitted by
Jews who migrated from the Middle East, whereas R1b and
certain sublineages within R1a may have entered the
Ashkenazi Jewish population in Europe.
Unique founder events are evident using detailed lineage
analyses of these seven Y chromosome biomarkers in the
Ashkenazi Jewish population (Behar et al. 2004). The
comparative frequencies of these lineages between con-
temporary Jews to European non-Jews led to an estimate of
an overall historical male admixture rate of 5–8 % with
European populations, since the founding of the Ashkenazi
Jewish population. This is the same as an admixture rate of
0.5 % per generation (Hammer et al. 2000). The presence
of European Y chromosomal lineages is the major differ-
ence between Ashkenazi Jews and Middle Eastern and
Sephardic Jews (Nebel et al. 2001).
Yet this Middle Eastern/European distinction in the
Ashkenazi gene pool may be an oversimplification. Some
of these Middle Eastern Y chromosomal lineages were
brought by Middle Eastern settlers during the Stone and
Bronze Ages colonization of Europe, then introduced
through admixture between Europeans and Jews (Semino
et al. 2000). The most common Ashkenazi Jewish Y
chromosomal types of European origin are R1a1 and R1b
with frequencies of 7.5 and 10 %, respectively. R1a1 is
very common among Russians, Ukrainians, and Sorbs
(Slavic speakers in Germany), as well as among certain
Central Asian groups. This may be the signal of much-
speculated Khazar admixture with Ashkenazi Jews,
although the admixture may have occurred with Ukraini-
ans, Poles or Russians (Nebel et al. 2005). However, it
should be noted that a Middle Eastern origin for some R1a1
lineages cannot be ruled out. R1b is the most common Y
chromosome branch of Atlantic Europe. Its occurrence
among Ashkenazi Jews may be an indicator of admixture
that occurred in the Rhine Valley prior to the Ashkenazi
Jewish migration to Eastern Europe or at later time points
in certain locales (Nebel et al. 2005). This branch is also
prevalent in Lebanon among the Maronite Christian com-
munity and may reflect the admixture with Crusaders fol-
lowing their invasions in the 11–13th centuries CE
(Zalloua et al. 2008).
Analysis of Jewish mitochondrial genomes in some
Diaspora communities has demonstrated limited genetic
diversity and therefore, evidence for strong founder effects.
Four mitochondrial haplogroups were found to account for
[40 % of the total among Ashkenazi Jews, providing
evidence for four founder females, with a limited number
of additional female founders accounting for of the
remainder (Behar et al. 2008). These haplogroups form the
so-called ‘‘star phylogenies’’ around a coalescent, ancestral
mitochondrial haplotype. At least some of these founders
clearly originate in the Middle East, with an overall pattern
similar to that observed for male Ashkenazi Jewish foun-
ders. Evidence for female founders has been observed in
other Jewish populations. The number of founders and the
relative proportion of founders vary greatly from one
Jewish Diaspora population to another. There are very few
founder lineages among the Jews of Azerbaijan, Georgia,
Libya, Mumbai, India, and Belmonte, Portugal, and these
lineages account for the majority of mitochondrial haplo-
types. In all of these populations, a sole founding mother
was sufficient to account for at least 40 % of the contem-
porary mitochondrial genomes. Among the Jews of Tunisia
and Cochin (south India), two founding mothers account
for 30 % of the mitochondrial genomes. In the Bulgarian,
Turkish, Moroccan, and Ethiopian Jewish communities,
there was no evidence for a narrow founder effect. The
Bulgarian, Turkish, and Moroccan communities all
received large influxes of Jewish refugees following the
Spanish Inquisition. The high degree of diversity observed
today probably reflects the degree of diversity that was
present among the Jews of Spain prior to the expulsion in
1492, and Portugal in 1496. The diversity observed among
the Ethiopian Jews reflects the variety of maternal lineages
that were present during the founding and propagation of
this community in East Africa. By contrast, the Iranian,
Iraqi, and Yemenite communities demonstrate a degree of
diversity that is intermediate to that observed in the other
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groups. The communities were all founded at least 2,000
years ago, and the mitochondrial genotypes are not con-
sistent with a narrow founding event with at least six
founding mothers in these populations. None of these
populations is quite like the Ashkenazi Jews which have a
large contemporary population base, but relatively few
founders.
With two exceptions, all of the populations had mito-
chondrial genomes that were of Middle Eastern origin. The
Ethiopian mitochondrial genomes were of African origin
and the Bene Israel of Indian origin. This demonstrates that
Jewish population origins have been determined not only
by the flow of genes, but also by the flow of ideas, although
this does not exclude the flow of genes from some now
undetected founder Jewish women at the time of formation
of a new Jewish community. This observation provides
some resolution to the queries of the physical anthropolo-
gists, Maurice Fishberg and Joseph Jacobs, for why Indian
and Ethiopian Jews bear a physical resemblance to their
local populations (Fishberg 1911; Jacobs 1899).
Insights from Jewish disease genetics (please see
supplementary table 1)
Genetic analyses of Mendelian diseases were utilized early
on as a means of understanding the population genetics of
the Jews and subsequently many other genetic isolates.
Chaim Sheba and Victor McKusick were key opinion
leaders in this regard, as typified by McKusick’s comment,
‘‘One of my most cherished memories is of ward rounds
with Dr. Chaim Sheba at Tel-Hashomer Hospital in 1964.
As we passed from bed to bed, Dr. Sheba would say ‘this is
a Moroccan Jew. They are particularly susceptible to dis-
eases A and B’ or ‘this is a Yemenite Jew. They are par-
ticularly susceptible to diseases C and D’. It was Dr. Sheba
who stimulated my interest in the ethnic distribution of
disease’’ (McKusick 1973). The advent of Israeli statehood
and the resulting immigration of Jewish Diaspora groups to
Israel provided an unprecedented opportunity for studying
these conditions. Richard Goodman described it this way,
‘‘After the State of Israel came into being in 1948, waves of
new immigrants from over 100 countries throughout the
world came by land, sea and air to the country. They were
literally met at their ports of entry by teams of physicians
and geneticists, seeking to learn about the heritable dif-
ferences and similarities of these people who had been
dispersed for over 2,000 years’’ (Goodman 1974). These
have included X-linked and autosomal dominant and
recessive Mendelian disorders that occur in individual
families, in specific Jewish Diaspora groups, across two or
more Diaspora groups or across Jewish and non-Jewish
groups (Goodman 1979; Ostrer 2001). These conditions
have been identified, because they have a recognizable
phenotype and commonly have an allele frequency
exceeding 0.05 in a population of interest. Comprehensive
characterization and cataloging has been carried out and is
included as part of the Israeli National Genetic Database
(http://www.goldenhelix.org/server/israeli/) coordinated by
Joel Zlotogora (van Baal et al. 2010). Molecular analysis
has usually identified one or two common alleles that
account for 70 % or more of the cases. Coalescence theory
has demonstrated that these mutations have arisen
throughout Jewish history and in some in the pre-Jewish
era (Ostrer 2001; Risch et al. 2003). Disease phenotype
causing mutations in a given Jewish Diaspora group have
been shown to coalesce typically to the founding of that
group. Both selection and drift have been proposed as
mechanisms for higher frequencies of such mutations
within Jewish Diaspora groups. However, the inferred
geographic distribution of Ashkenazi Jewish mutation
carriers in Europe supported drift over selection (Risch
et al. 2003). Likewise, the observation that Ashkenazi
Jewish founder mutations did not reject the neutrality
hypothesis in the Slatkin–Bertorelle test also supported
drift (Slatkin 2004). Malaria resistance for the G6PDMed
mutation is the only proven example of a role for selection
(Motulsky et al. 1966). However, many of these conditions
do seem to cluster into specific categories, including
lysosomal storage diseases (Tay-Sachs disease, Niemann-
Pick disease, Gaucher disease and mucolipidosis IV),
glycogen storage disease (types I and III), clotting factor
deficiencies (factor XI deficiency, factor VII deficiency,
combined factors V and VIII deficiency), steroid hormone
biosynthetic defects (21-hydroxylase deficiency,
11-hydroxylase deficiency, and corticosterone methyloxi-
dase II deficiency), and defects in DNA repair that increase
susceptibility to cancer (hereditary breast-ovarian cancer
susceptibility caused by mutations in BRCA1 or BRCA2,
Bloom syndrome, and Fanconi anemia) (Ostrer 2001). The
reason for this clustering of diseases is not known, but does
favor the idea of a common selective pressure conferring
advantage to the heterozygote state across disease muta-
tions in the same cluster. Contemporary methods of
genomic analysis are starting to provide evidence for
selection of other variants in the genome without evidence
for the selective agents (Bray et al. 2010).
The study of these conditions has been translated into
public health genetics initiatives for Jews, and where the
same conditions occur, non-Jews alike. These have inclu-
ded genetic screening programs for reproductive risks,
presymptomatic identification of disease risk, and treat-
ment of genetic disease. Screening for Tay-Sachs disease
has been available for Ashkenazi Jews since the 1970s
(Kaback 2001). This has taken many forms, both com-
munity-based and medically based. Thousands of people
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come each year for genetic testing, both pregnant couples
trying to decide, whether they should have prenatal diag-
nosis via amniocentesis and young Orthodox Jewish men
and women contemplating marriage, but wanting to obtain
genetic information before developing a serious relation-
ship. Over a million people have had Tay-Sachs carrier
testing and this has decreased the number of Tay-Sachs
births. Currently, 4–5 children are born each year with Tay-
Sachs disease, in contrast to the 40–50 annually prior to
genetic screening. Ashkenazi Jews are now screened typi-
cally for 18 conditions and this number is likely to rise.
New genetic testing programs are also being developed for
Sephardic and Middle Eastern Jews, with the goal of pre-
empting the tragic conception or birth of a child with a fatal
genetic disease. In the past, when a couple had a child with
a genetic disease, oftentimes they stopped having children.
Screening for genetic diseases has been accepted into the
mainstream of Judaism. It should be kept in mind that the
growing accessibility of whole-exome and eventually
whole genome sequence information is likely to change the
landscape of such public initiatives in genetic testing for
Jewish and other populations alike.
The second way in which genetic knowledge has
impacted medically has been in the treatment of genetic
disease. One of the dramatic examples is the treatment of
Gaucher disease, a lysosomal storage disease that results
in accumulation of glucocerebroside into the lysosomes of
cells (Charrow 2009). People with Gaucher disease can be
quite disabled with bleeding, bone pain, hip fractures, and
large spleens. Knowledge of the genetic defect in Gaucher
disease led to a specific therapy in which the enzyme that
is missing from the people with the disease is replaced by
injection. The results of treatment are dramatic with
normalization of bleeding times, reduced bone pain,
elimination of hip fractures. Gaucher was the first disease
in which enzyme-replacement therapy was used success-
fully. Recent studies have also led to an appreciation of
the relationship between the carrier state for Gaucher’s
disease and Parkinson’s disease (Aharon-Peretz et al.
2005).
A third example relates to oncogenetics and in particular
genetic testing for breast and ovarian cancer (Robson and
Offit 2007). Clustering of some forms of cancer in families
has been well documented (Goldgar et al. 1994; Simchoni
et al. 2006). Some women come from high-risk families
with mothers and sisters, aunts, and cousins affected with
breast and/or ovarian cancer. Gene mapping studies in
multiple extended families with early-onset breast and
ovarian cancer led to the identification of the BRCA1 and
BRCA2 genes as harboring germline breast and ovarian
cancer risk mutations. Among Ashkenazi Jews, three
mutations are common and make genetic testing simple
and relatively inexpensive (Oddoux et al. 1996). Genetic
testing has led to prevention of cancers through life-pre-
serving prophylactic oophorectomy and mastectomy.
Ashkenazi Jews may also be in the vanguard for popula-
tion-based genetic screening for breast and ovarian cancer
risk. In 2009, Dr. Wendy Rubinstein and colleagues
reported that almost half of Ashkenazi Jews identified with
BRCA1/2 cancer-risk mutations have negative family his-
tories for cancer. The absence of a family history confounds
efforts toward presymptomatic carrier identification. Their
model predicted that a genetic screening program would
result in 2,811 fewer cases of ovarian cancer, with a life
expectancy gain of 1.83 quality-adjusted life years among
carriers at a cost of $8,300 (discounted) per year of quality-
adjusted life gained (Rubinstein et al. 2009). Their recom-
mendations were at odds with earlier recommendations
of the US Preventive Services Task Force that population-
based genetic screening for BRCA1/2 should not be
offered.
Toward a personalized medicine for the Jewish people
based on genomics
Genome-wide analysis holds the prospect of understanding
all of the genetic risks of the Jewish people and translating
these into surveillance and treatment programs that will
prevent disease or optimize therapy and minimize toxicity
when disease does occur. Multiple genome-wide associa-
tion studies (GWAS) for common diseases have been
mounted for conditions that are either more prevalent
among Ashkenazi Jews (Crohn disease, Parkinson disease)
or premised to have less genetic heterogeneity compared
with European or European–American populations (breast
cancer, diabetes, bipolar disease, schizophrenia). Notably,
these GWAS have identified disease-associated variants in
the AJ population that were not identified in other popu-
lations (Avramopoulos et al. 2007; Liu et al. 2011; Nish-
ioka et al. 2010; Shifman et al. 2008). Sequencing
strategies hold the possibility of identifying both common
and rare variants that affect disease risk as well as response
to therapy and development of toxicity.
This work will be of importance in both the United
States and Israel. Ashkenazi Jews are America’s largest
genetic isolate, numbering some 6 million people or 2 % of
the population. Based on patterns of participation in earlier
genetic studies, it seems likely that members of this group
will embrace new genomic medicine studies. All Jewish
Diaspora groups are represented in Israel and receive their
care through one of only four nationwide mandatory health
care organizations. Linking their medical records (with
adequate privacy safeguards) will provide an opportunity
to identify the genetic factors that influence disease onset
and progression and the therapeutic response.
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